THENA Capital News

THENA Capital Rings the Closing BellAbout This EventTHENA Capital, an early stage specialist MedTech Venture Capital fund, visits the Nasdaq MarketSite in Times Square. THENA Capital is the UK’s first early stage MedTech fund and the first all-female GP team to be backed by the UK’s largest private market investor, the British Business Bank. The fund is dedicated to advancing the future of healthcare across the UK and USA through investments into life changing technologies that transform the patient experience.

How THENA Capital Tackles the Challenges UK Medtech Founders Face Expanding to the USImage: THENA Capital UK-based VC firm THENA Capital has recently reached another milestone with a second close, bringing total commitments to almost £34M of its £50M fund targeting early-stage UK medtech companies. What sets the fund apart...

Thena Capital’s New Fund Up And Running With £1M Investment In Plexāā’s Breast Cancer DeviceThena Capital, the first UK-based early-stage specialist medtech firm, has made its first investment since closing its £50m fund. Medtech Insight spoke with general partner Pamela Walker Geddes to gain insight into Thena Capital’s investment strategy.

Salient Bio Raises £2.35M to Launch IBD Diagnostic Test and Focus on Women’s HealthThe Salient Bio and THENA Capital teams. Image: Salient Bio UK-based diagnostics company Salient Bio has closed a £2.35 million seed funding round led by THENA Capital to support the commercial launch of its microbiome-based diagnostic test...

THENA Updates

Disclaimer

This is not an offer to sell any direct or indirect interest in THENA Capital, the fund or any other entity, and is not soliciting an offer to purchase any direct or indirect interest.

THENA Capital LLP is an Appointed Representative of The Fund Incubator Limited (FRN 208716), which is authorised and regulated by the Financial Conduct Authority

Page updated

Report abuse